Breanna J Joiner1, Amber L Simpson2,3, Julie N Leal2, Michael I D'Angelica2, Richard K G Do4. 1. Sophie Davis School of Biomedical Education, The City College of New York, 160 Convent Ave, New York, NY, 10031, USA. 2. Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. 3. Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. 4. Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. dok@mskcc.org.
Abstract
PURPOSE: The aim of this study was to assess splenic volume and to correlate unidimensional measurements with reference volumetric changes in chemotherapy-treated patients with colorectal cancer (CRC) liver metastases. METHODS: Forty consecutive patients were selected from the cohort of a previously reported study of chemotherapy-related morbidity following major hepatectomy for CRC liver metastases. Patients were treated for 6 months prior to resection, with imaging performed at baseline and after 6 months of chemotherapy. Three unidimensional spleen measurements were recorded-width, thickness, and height (W, T, and H). Reference splenic volume was measured at baseline and after chemotherapy. The best unidimensional splenic measurement was determined by regression analysis. The 95% CI for the predicted values and R (2) values was calculated for each regression. The percentage of volume increase at 6 months was calculated. RESULTS: W and H showed the highest correlation with splenic volume prior to and following chemotherapy (R (2) = 0.65-0.74, p < 0.001), while T showed a low correlation (R (2) = 0.11 and 0.18, p < 0.05). The mean reference splenic volume increased after 6 months of chemotherapy compared to baseline (326 vs. 278 mL). Splenic volume changes showed the highest correlation with changes in W (R (2) = 0.56, p < 0.001), then H (R (2) = 0.40, p < 0.001), but were not significantly correlated with changes in T (R (2) = 0.01, p = 0.055). CONCLUSIONS: Our results show the potential utility of measuring changes in splenic width to predict clinically significant changes in splenic volume in chemotherapy-treated patients with CRC liver metastases.
PURPOSE: The aim of this study was to assess splenic volume and to correlate unidimensional measurements with reference volumetric changes in chemotherapy-treated patients with colorectal cancer (CRC) liver metastases. METHODS: Forty consecutive patients were selected from the cohort of a previously reported study of chemotherapy-related morbidity following major hepatectomy for CRC liver metastases. Patients were treated for 6 months prior to resection, with imaging performed at baseline and after 6 months of chemotherapy. Three unidimensional spleen measurements were recorded-width, thickness, and height (W, T, and H). Reference splenic volume was measured at baseline and after chemotherapy. The best unidimensional splenic measurement was determined by regression analysis. The 95% CI for the predicted values and R (2) values was calculated for each regression. The percentage of volume increase at 6 months was calculated. RESULTS:W and H showed the highest correlation with splenic volume prior to and following chemotherapy (R (2) = 0.65-0.74, p < 0.001), while T showed a low correlation (R (2) = 0.11 and 0.18, p < 0.05). The mean reference splenic volume increased after 6 months of chemotherapy compared to baseline (326 vs. 278 mL). Splenic volume changes showed the highest correlation with changes in W (R (2) = 0.56, p < 0.001), then H (R (2) = 0.40, p < 0.001), but were not significantly correlated with changes in T (R (2) = 0.01, p = 0.055). CONCLUSIONS: Our results show the potential utility of measuring changes in splenic width to predict clinically significant changes in splenic volume in chemotherapy-treated patients with CRC liver metastases.
Authors: Alexandre S Bezerra; Giuseppe D'Ippolito; Salomão Faintuch; Jacob Szejnfeld; Muneeb Ahmed Journal: AJR Am J Roentgenol Date: 2005-05 Impact factor: 3.959
Authors: Michael J Overman; Dipen M Maru; Chusilp Charnsangavej; Evelyn M Loyer; Huamin Wang; Priyanka Pathak; Cathy Eng; Paulo M Hoff; Jean-Nicolas Vauthey; Robert A Wolff; Scott Kopetz Journal: J Clin Oncol Date: 2010-04-20 Impact factor: 44.544
Authors: Amber L Simpson; Julie N Leal; Amudhan Pugalenthi; Peter J Allen; Ronald P DeMatteo; Yuman Fong; Mithat Gönen; William R Jarnagin; T Peter Kingham; Michael I Miga; Jinru Shia; Martin R Weiser; Michael I D'Angelica Journal: J Am Coll Surg Date: 2014-12-13 Impact factor: 6.113
Authors: Eun-Joo Jung; Chun-Geun Ryu; Gangmi Kim; Su Ran Kim; Hee Sun Park; Young Jun Kim; Dae-Yong Hwang Journal: Anticancer Res Date: 2012-08 Impact factor: 2.480
Authors: Patrick S Wolf; James O Park; Fei Bao; Peter J Allen; Ronald P DeMatteo; Yuman Fong; William R Jarnagin; T Peter Kingham; Mithat Gönen; Nancy Kemeny; Jinru Shia; Michael I D'Angelica Journal: J Am Coll Surg Date: 2012-10-05 Impact factor: 6.113
Authors: Revathi Angitapalli; Alan M Litwin; Prasanna R G Kumar; Eiad Nasser; Jeffrey Lombardo; Terry Mashtare; Gregory E Wilding; Marwan G Fakih Journal: Oncology Date: 2009-03-25 Impact factor: 2.935
Authors: Gabriel E Humpire-Mamani; Joris Bukala; Ernst T Scholten; Mathias Prokop; Bram van Ginneken; Colin Jacobs Journal: Radiol Artif Intell Date: 2020-07-22